HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.

Abstract
Spinal cord injury (SCI) is a traumatic event that causes a secondary and extended inflammation characterized by infiltration of immune cells, including T lymphocytes, release of pro-inflammatory mediators in the lesion site, and tissue degeneration. Current therapeutic approaches for SCI are limited to glucocorticoids (GC) due to their potent anti-inflammatory activity. GC efficacy resides, in part, in the capability to inhibit NF-κB, T lymphocyte activation, and the consequent cytokine production. In this study, we performed experiments aimed to test the susceptibility of glucocorticoid-induced leucine zipper (GILZ) transgenic (GILZ(TG)) mice, in which GILZ is selectively over-expressed in T lymphocytes, to SCI induction. Consistent with a decreased inflammatory response, GILZ(TG) were less susceptible to SCI as compared to wild-type littermates. Notably, inhibition of NF-κB activation and nuclear translocation, diminished T lymphocytes activation and tissue infiltration, as well as decreased release of cytokines were evident in GILZ(TG) as compared to wild-type mice. Moreover, GILZ(TG) showed a reduced tumor necrosis factor-α, IL-1β, Inductible nitric oxide synthase (iNOS) and nytrotyrosine production, apoptosis, and neuronal tissue damage. Together these results indicate that GILZ mimics the anti-inflammatory effect of GC and represents a potential pharmacological target for modulation of T lymphocyte-mediated immune response in inflammatory disorders, such as SCI.
AuthorsEmanuela Esposito, Stefano Bruscoli, Emanuela Mazzon, Irene Paterniti, Maddalena Coppo, Enrico Velardi, Salvatore Cuzzocrea, Carlo Riccardi
JournalNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (Neurotherapeutics) Vol. 9 Issue 1 Pg. 210-25 (Jan 2012) ISSN: 1878-7479 [Electronic] United States
PMID22125095 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Dsip1 protein, mouse
  • Glial Fibrillary Acidic Protein
  • Transcription Factors
  • bcl-2-Associated X Protein
  • Cyclin D1
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Dinoprostone
Topics
  • Animals
  • Apoptosis (genetics)
  • Cyclin D1 (metabolism)
  • Cytokines (metabolism)
  • Dinoprostone (metabolism)
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression Regulation (genetics, physiology)
  • Glial Fibrillary Acidic Protein (metabolism)
  • In Situ Nick-End Labeling
  • Inflammation (etiology, genetics, metabolism, pathology)
  • Mice
  • Mice, Transgenic
  • Nitric Oxide Synthase Type II (metabolism)
  • Peroxidase (metabolism)
  • Signal Transduction (genetics)
  • Spinal Cord Injuries (complications, pathology)
  • T-Lymphocytes (metabolism)
  • Transcription Factors (genetics, metabolism)
  • bcl-2-Associated X Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: